Rapid Micro Biosystems, Inc.: operating lease liability
Operating lease liability for Rapid Micro Biosystems, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Rapid Micro Biosystems, Inc. financial histories
What this measure means
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
Exact concept: us-gaap:OperatingLeaseLiability. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 4,785,000 | USD | 2026-03-12 | 10-K · 0001380106-26-000034 |
| At date | 2024-12-31 | 5,951,000 | USD | 2026-03-12 | 10-K · 0001380106-26-000034 |
| At date | 2023-12-31 | 7,042,000 | USD | 2025-02-28 | 10-K · 0001380106-25-000058 |
| At date | 2022-12-31 | 7,627,000 | USD | 2024-03-01 | 10-K · 0001380106-24-000073 |
Related financial histories
- Rapid Micro Biosystems, Inc.: total assets
- Rapid Micro Biosystems, Inc.: total liabilities
- Rapid Micro Biosystems, Inc.: stockholders equity
- Rapid Micro Biosystems, Inc.: cash and cash equivalents
- Rapid Micro Biosystems, Inc.: net income or loss
- Rapid Micro Biosystems, Inc.: operating cash flow
- Rapid Micro Biosystems, Inc.: capital expenditure payments
- Rapid Micro Biosystems, Inc.: contract revenue excluding tax
- Rapid Micro Biosystems, Inc.: financing cash flow
- Rapid Micro Biosystems, Inc.: investing cash flow
- Rapid Micro Biosystems, Inc.: retained earnings or deficit
- Rapid Micro Biosystems, Inc.: basic weighted-average shares
- Rapid Micro Biosystems, Inc.: diluted weighted-average shares
- Rapid Micro Biosystems, Inc.: basic earnings per share
- Rapid Micro Biosystems, Inc.: diluted earnings per share
- Rapid Micro Biosystems, Inc.: income tax expense or benefit
- Rapid Micro Biosystems, Inc.: net property, plant and equipment
- Rapid Micro Biosystems, Inc.: share-based compensation expense
- Rapid Micro Biosystems, Inc.: operating income or loss
- Rapid Micro Biosystems, Inc.: current assets
- Rapid Micro Biosystems, Inc.: current liabilities
- Rapid Micro Biosystems, Inc.: current accounts payable
- Rapid Micro Biosystems, Inc.: net current accounts receivable
- Rapid Micro Biosystems, Inc.: net inventory
- Rapid Micro Biosystems, Inc.: research and development expense
- Rapid Micro Biosystems, Inc.: cash including restricted cash
- Rapid Micro Biosystems, Inc.: additional paid-in capital
- Rapid Micro Biosystems, Inc.: accumulated other comprehensive income or loss
- Rapid Micro Biosystems, Inc.: operating lease right-of-use asset
- Rapid Micro Biosystems, Inc.: long-term debt
- Rapid Micro Biosystems, Inc.: gross property, plant and equipment
- Rapid Micro Biosystems, Inc.: accumulated depreciation on property, plant and equipment
- Rapid Micro Biosystems, Inc.: other noncurrent assets
- Rapid Micro Biosystems, Inc.: other noncurrent liabilities
- Rapid Micro Biosystems, Inc.: accrued current liabilities
- Rapid Micro Biosystems, Inc.: prepaid expenses and other current assets
- Rapid Micro Biosystems, Inc.: current contract liabilities
- Rapid Micro Biosystems, Inc.: net deferred tax assets
- Rapid Micro Biosystems, Inc.: pre-tax income or loss from continuing operations
- Rapid Micro Biosystems, Inc.: comprehensive income or loss
- Rapid Micro Biosystems, Inc.: net income available to common stockholders
- Rapid Micro Biosystems, Inc.: general and administrative expense
- Rapid Micro Biosystems, Inc.: depreciation, depletion and amortization
- Rapid Micro Biosystems, Inc.: other nonoperating income or expense
- Rapid Micro Biosystems, Inc.: nonoperating income or expense
- Rapid Micro Biosystems, Inc.: current income tax expense or benefit
- Rapid Micro Biosystems, Inc.: deferred income tax expense or benefit
- Rapid Micro Biosystems, Inc.: interest paid, net
- Rapid Micro Biosystems, Inc.: operating lease payments
- Rapid Micro Biosystems, Inc.: change in accounts receivable
- Rapid Micro Biosystems, Inc.: change in inventories
- Rapid Micro Biosystems, Inc.: change in accounts payable
Inspect the source
- Entity
- Rapid Micro Biosystems, Inc. / CIK 0001380106
- Captured
- 2026-09-20T07:58:12.217Z
- SEC response SHA-256
8c4362d2b05e0f4a0adf4f8af9763ce28a8aa93bae8a254f07b04a87d0491d12
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001380106.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))